A Radioimmunoassay for Ovarian Cancer

Abstract

AS many women die from ovarian cancer in the United States each year as from all other cancers of the genital tract combined. ¹ If for no other reason, any development that raises the hope of improving our ability to diagnose or treat this cancer deserves attention.Because of its histologic complexity, the ovary gives rise to benign and malignant tumors of epithelial, stromal, and germ-cell origin.² Epithelial tumors (serous, mucinous, endometrioid, clear-cell, and undifferentiated) account for about 90 per cent of ovarian carcinomas. Ovarian cancers spread early. This characteristic, along with the lack of early signs or symptoms, accounts for . . .